Literature DB >> 1611370

Toxicity of norpethidine in sickle cell crisis.

B J Pryle1, H Grech, P A Stoddart, R Carson, T O'Mahoney, F Reynolds.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1611370      PMCID： PMC1882223          DOI： 10.1136/bmj.304.6840.1478

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Pethidine for painful crises in sickle cell disease.

Authors:  A Mitchell; A P Fisher; M Brunner; R G Ware; M Hanna
Journal:  BMJ       Date:  1991-07-27

2.  Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer.

Authors:  H H Szeto; C E Inturrisi; R Houde; S Saal; J Cheigh; M M Reidenberg
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

3.  Central nervous system excitatory effects of meperidine in cancer patients.

Authors:  R F Kaiko; K M Foley; P Y Grabinski; G Heidrich; A G Rogers; C E Inturrisi; M M Reidenberg
Journal:  Ann Neurol       Date:  1983-02       Impact factor: 10.422
  3 in total
  5 in total

1.  Pethidine in sickle cell crisis.

Authors:  J F Harrison; R Liesner; S C Davies
Journal:  BMJ       Date:  1992-07-18

Review 2.  Strong opioids in pediatric palliative medicine.

Authors:  Richard D W Hain; Angela Miser; Mary Devins; W Hamish B Wallace
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

3.  Management of sickle cell disease. Non-addictive analgesics can be as effective as morphine and pethidine.

Authors:  Y M Agble
Journal:  BMJ       Date:  1998-03-21

4.  Fast track admission for children with sickle cell crises. Should morphine or pethidine be given?

Authors:  P Daggett
Journal:  BMJ       Date:  1998-03-21

Review 5.  Seizures and Meperidine: Overstated and Underutilized.

Authors:  Konrad H Schlick; Thomas M Hemmen; Patrick D Lyden
Journal:  Ther Hypothermia Temp Manag       Date:  2015-06-18       Impact factor: 1.286
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.